Lorigerlimab

Drug identity checked against registry records

Also recorded as MGD019

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Lorigerlimab in Participants With Advanced Solid TumorsNCT06730347MacroGenicsPhase 2Recruiting2027-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.